Aehr Test Systems

PoseDel Rhea J sells 13,998 Aehr Test Systems shares at $30.02—an ordinary portfolio move, not a warning, amid AI‑chip contract gains and market rally.

Insider sale by Aehr Test Systems’ director Laura Oliphant raises warning flags as the company faces negative earnings and high volatility—investors should watch closely.

Insider selling of Aehr Test Systems shares sparks debate—executives dump stock while prices rise. Learn why the trend may not spell doom and what it means for investors in the booming memory‑testing sector.

Insider sales at Aehr Test Systems reveal short‑term liquidity needs, not lost confidence—investors should monitor earnings, P/E, and market buzz for volatility signals.

Insider selling surges at Aehr Test Systems—executives dump 15K+ shares in a month. Learn what this means for investors and the company’s future.

CEO Erickson Gayn’s recent sale of 3,531 Aehr Test Systems shares raises questions for investors: Is it a liquidity move or a signal of falling confidence amid a 12% rally and negative PE? Gain insights into insider trends, market sentiment, and wha…

CTO Richmond Donald P. II’s recent sale of 576 Aehr Test Systems shares signals caution amid a 125 % rally, raising investor questions about short‑term momentum.